
    
      This study will use functional magnetic resonance imaging (fMRI) to study patients treated
      with risperidone, a commonly used neuroleptic that does not improves sensory gating, to those
      treated with clozapine to determine which brain areas are involved in clozapine's
      normalization of sensory gating in schizophrenia.
    
  